Molecular ablation of ventricular tachycardia after myocardial infarction

@article{Sasano2006MolecularAO,
  title={Molecular ablation of ventricular tachycardia after myocardial infarction},
  author={Tetsuo Sasano and Amy D. McDonald and Kan Kikuchi and J Kevin Donahue},
  journal={Nature Medicine},
  year={2006},
  volume={12},
  pages={1256-1258}
}
Ventricular tachycardia is a common and lethal complication after myocardial infarction. Here we show that focal transfer of a gene encoding a dominant-negative version of the KCNH2 potassium channel (KCNH2-G628S) to the infarct scar border eliminated all ventricular arrhythmias in a porcine model. No proarrhythmia or other negative effects were discernable. Our results demonstrate the potential viability of gene therapy for ablation of ventricular arrhythmias. 

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 48 extracted citations

Gene therapies for arrhythmias in heart failure

Pflügers Archiv - European Journal of Physiology • 2014
View 3 Excerpts
Highly Influenced

Gene therapy to keep the QT rhythms "on the QT".

The Journal of thoracic and cardiovascular surgery • 2017

Status of Therapeutic Gene Transfer to Treat Cardiovascular Disease in Dogs and Cats.

The Veterinary clinics of North America. Small animal practice • 2017

References

Publications referenced by this paper.
Showing 1-2 of 2 references

Canadian Heart Rhythm Society Working Group on Device Advisories

P. Gould, A. Krahn
JAMA • 1997

NATURE MEDICINE © 20 06 N at ur e P ub lis hi ng G ro up ht tp :// w w w .n at ur e

T Kafri
Nat. Genet • 1997

Similar Papers

Loading similar papers…